New Edge Wealth, LLC Sarepta Therapeutics, Inc. Transaction History

New Edge Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $532 - $785	-5 Reduced 0.17%	2,858 $327,000
Q1 2023 May 08, 2023	SELL	$117.53 - $155.99 $2,938 - $3,899	-25 Reduced 0.87%	2,863 $394,000
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $54,968 - $72,010	-545 Reduced 15.88%	2,888 $374,000
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $104,025 - $163,835	-1,374 Reduced 28.58%	3,433 $379,000
Q2 2022 Aug 09, 2022	SELL	$62.69 - $88.44 $72,908 - $102,855	-1,163 Reduced 19.48%	4,807 $360,000
Q1 2022 May 10, 2022	SELL	$63.15 - $90.42 $61,192 - $87,616	-969 Reduced 13.96%	5,970 $466,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $38,064 - $53,360	577 Added 9.07%	6,939 $642,000
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $27,058 - $33,832	390 Added 6.53%	6,362 $495,000
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $431,477 - $1.01 Million	5,972 New	5,972 $445,000

530

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Wealth, LLC with notifications on news.